AI in Drug Manufacturing: Operational Strategies, Market Trends, and Commercial Outlook

This technological evolution is driving significant market expansion and capital investment across global life sciences sectors. According to a detailed AI in drug manufacturing market research report by Roots Analysis, the global market is estimated to grow from USD 0.9 billion in 2025 to reach USD 1.2 billion in 2026 and USD 34.8 billion by 2040, representing a CAGR of 27.2% during the forecast period 2026 to 2040. Commercial momentum is fueled by the urgent requirement for higher batch yields, reduced raw material waste, and streamlined regulatory compliance across complex drug development pipelines.